Cartesian Therapeutics, Inc. (RNAC) Current Ratio
- Current ratio · latest quarter: Value 7.48×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 7.48× | Current assets / current liabilities. $153.62M ÷ $20.55M ≈ 7.48× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 153.62M USD | Assets, Current |
| Current obligations | 20.55M USD | Liabilities, Current |
| Cash and equivalents | 147.61M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | 196.00K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | 1.05M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $153.62M | $20.55M | $147.61M | (m) | $196.00K | (m) | $1.05M | (m) | 7.48× |
| 2026-03-31 | $122.04M | $15.95M | $118.64M | (m) | $261.00K | (m) | $1.60M | (m) | 7.65× |
| 2025-12-31 | $129.28M | $14.94M | $125.14M | (m) | $1.11M | (m) | $1.29M | (m) | 8.65× |
| 2025-09-30 | $147.26M | $13.80M | $143.38M | (m) | $722.00K | (m) | $2.23M | (m) | 10.67× |
| 2025-06-30 | $163.40M | $12.26M | $160.32M | (m) | $354.00K | (m) | $454.00K | (m) | 13.33× |
| 2025-03-31 | $185.12M | $15.00M | $180.43M | (m) | $1.76M | (m) | $2.10M | (m) | 12.34× |
| 2024-12-31 | $216.63M | $22.98M | $212.61M | (m) | $872.00K | (m) | $288.00K | (m) | 9.43× |
| 2024-09-30 | $229.14M | $21.41M | $219.20M | (m) | $4.83M | (m) | $517.00K | (m) | 10.70× |
| 2024-06-30 | $124.78M | $26.11M | $87.23M | (m) | $32.04M | (m) | $2.86M | (m) | 4.78× |
| 2024-03-31 | $111.11M | $36.65M | $103.42M | (m) | $2.01M | (m) | $2.52M | (m) | 3.03× |
| 2023-12-31 | $90.73M | $68.21M | $76.91M | (m) | $5.87M | (m) | $3.15M | (m) | 1.33× |
| 2023-09-30 | $89.87M | $19.94M | $79.60M | $0.00 | $4.90M | (m) | $375.00K | (m) | 4.51× |
| 2023-06-30 | $122.72M | $29.37M | $112.03M | $0.00 | $5.38M | (m) | $267.00K | (m) | 4.18× |
| 2023-03-31 | $138.39M | $26.53M | $125.92M | $0.00 | $6.84M | (m) | $1.06M | (m) | 5.22× |
| 2022-12-31 | $148.14M | $25.08M | $106.44M | $28.16M | $6.60M | (m) | $316.00K | (m) | 5.91× |
| 2022-09-30 | $159.68M | $23.73M | $112.84M | $33.60M | $6.92M | (m) | $214.00K | (m) | 6.73× |
| 2022-06-30 | $172.57M | $33.76M | $138.06M | $4.00M | $23.99M | (m) | $693.00K | (m) | 5.11× |
| 2022-03-31 | $130.01M | $39.25M | $113.44M | $4.00M | $7.15M | (m) | $264.00K | (m) | 3.31× |
| 2021-12-31 | $144.44M | $72.25M | $114.06M | $14.00M | $9.91M | (m) | $224.00K | (m) | 2.00× |
| 2021-09-30 | $151.77M | $95.62M | $114.64M | $24.02M | $7.32M | (m) | $1.59M | (m) | 1.59× |
| 2021-06-30 | $166.81M | $87.30M | $125.75M | $24.39M | $8.46M | (m) | $154.00K | (m) | 1.91× |
| 2021-03-31 | $163.13M | $84.61M | $125.41M | $22.41M | $8.34M | (m) | $594.00K | (m) | 1.93× |
| 2020-12-31 | $151.34M | $81.55M | $138.69M | $0.00 | $7.22M | (m) | $443.00K | (m) | 1.86× |
| 2020-09-30 | $166.50M | $77.00M | $146.26M | (m) | $12.63M | (m) | $471.00K | (m) | 2.16× |
| 2020-06-30 | $61.05M | $22.51M | $59.73M | (m) | $0.00 | (m) | $1.24M | (m) | 2.71× |
| 2020-03-31 | $74.44M | $30.07M | $72.61M | (m) | $0.00 | (m) | $1.33M | (m) | 2.48× |
| 2019-12-31 | $96.67M | $34.94M | $89.89M | (m) | $5.00M | (m) | $500.00K | (m) | 2.77× |
| 2019-09-30 | $36.12M | $29.48M | $34.23M | (m) | (m) | (m) | $1.48M | (m) | 1.23× |
| 2019-06-30 | $44.45M | $31.91M | $30.20M | (m) | (m) | (m) | $2.46M | (m) | 1.39× |
| 2019-03-31 | $59.53M | $33.05M | $32.17M | (m) | (m) | (m) | $693.00K | (m) | 1.80× |
| 2018-12-31 | $42.08M | $35.14M | $37.40M | (m) | $0.00 | (m) | $1.10M | (m) | 1.20× |
| 2018-09-30 | $55.57M | $34.63M | $50.48M | (m) | (m) | (m) | $1.25M | (m) | 1.60× |
| 2018-06-30 | $68.83M | $13.89M | $60.24M | (m) | (m) | (m) | $1.79M | (m) | 4.96× |
| 2018-03-31 | $84.98M | $11.81M | $58.23M | (m) | $52.00K | (m) | $1.79M | (m) | 7.20× |
| 2018-01-01 | $98.68M | $10.97M | (m) | (m) | (m) | (m) | $1.61M | (m) | 8.99× |
| 2017-12-31 | $98.68M | $10.97M | $70.62M | (m) | (m) | (m) | $1.61M | (m) | 8.99× |
| 2017-09-30 | $107.35M | $11.32M | $72.15M | (m) | $0.00 | (m) | $1.52M | (m) | 9.48× |
| 2017-06-30 | $114.58M | $20.05M | $82.63M | (m) | $1.00K | (m) | $4.28M | (m) | 5.71× |
| 2017-03-31 | $71.49M | $13.30M | $26.64M | (m) | $63.00K | (m) | $1.32M | (m) | 5.37× |
| 2016-12-31 | $86.82M | $13.71M | $58.66M | (m) | $215.00K | (m) | $3.88M | (m) | 6.33× |
| 2016-09-30 | $83.40M | $7.69M | $59.49M | (m) | $483.00K | (m) | $1.04M | (m) | 10.84× |
| 2016-06-30 | $89.05M | $8.94M | $82.65M | (m) | $1.96M | (m) | $943.00K | (m) | 9.96× |
| 2015-12-31 | $38.91M | $7.29M | $32.34M | (m) | $824.00K | (m) | $2.18M | (m) | 5.34× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |